Symphogen, a key part of the global Servier Group, pioneers the development of antibody-based therapeutics. We combine scientific excellence with a collaborative culture to bring meaningful therapies to patients worldwide.
You-ll join the Purification Team, part of the Drug Substance Development group within our CMC department. Together, we develop and transfer downstream processes that enable the production and clinical supply of antibody-based biologics-working closely with CDMOs and contributing to regulatory submissions.
Responsibilities
- Develop, optimize, and scale up purification processes for antibody-based biologics
- Lead tech transfer to external CDMOs, providing scientific and technical oversight
- Support regulatory filings with process development documentation
- Drive innovation by evaluating and integrating new purification technologies
Your Background
- Master-s degree in Biotechnology, Biochemistry, Engineering-or PhD, depending on experience
- 6+ years in biopharma or biotech industry
- Strong foundation in downstream processing and CMC development
- Hands-on experience with purification of complex antibody formats
- Skilled in balancing technical depth with pragmatic project execution
- Agile, results-driven, and comfortable with shifting priorities and timelines
Why Join Symphogen?
- Impact Work:Help bring innovative antibody therapies to patients
- Team Environment:Work in a science-driven, cross-functional environment
- International Exposure:Expand your skills in a dynamic, international biotech organization
- Skill Development:Take the lead in your field with real responsibility
- Attractive Package:Competitive salary and comprehensive benefits
Contact
Symphogen is inspired by nature, led by science, and driven by people. If you’re ready to advance next-generation biologics, we-d love to hear from you.
Apply via AIMS International: https://www.linkedin.com/jobs/view/4253143983/
For more information about AIMS International: www.aimsinternational.com
Company
Symphogen is a subsidiary of Servier and antibody center of excellence primarily focused on oncology and immune oncology. We have a highly efficient antibody discovery and research platform supported by comprehensive early development capabilities.
Our antibody platform delivers antibodies with unique functionalities providing best or first in class potential as combination or mono therapy. Our approach and capabilities are well suited for combination therapies at the core of future cancer treatment.
Symphogen is located in Ballerup in the greater Copenhagen area. The company currently employs approximately 150 people